Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award

Per-recipient award not stated for others (see text field entitled "additional information on eligibility" for clarification).

Others (see text field entitled "Additional Information on Eligibility" for clarification)Health & Human Services

In one sentence

Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award does not state a per-recipient award amount, open to others (see text field entitled "additional information on eligibility" for clarification).

Record fields
Program pool (total)
Not confirmed
Total across all awards in this programme. Not an amount any single applicant can receive.
Award ceiling (per project)
Not confirmed
Award floor
Not confirmed
Typical award
Not confirmed
Deadline
Not stated
Deadline type
Not stated
Opens
Sep 1, 2026
Status
Forecasted
Eligible entities
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Geography
Not stated
Matching funds
No
Disbursement
Not confirmed
Application effort
Not confirmed
Use of funds
collaborative development of innovative approaches, technologies, or models · enhance the impact of research · advance translational science · bring more treatments for all people more quickly
Currency
USD

How much money is available?

Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.

Program pool (total)Across all awards this cycle
Not stated
Award ceiling (per project)The most one applicant can receive
Not stated

Who can apply?

level
Derived from the source that published this record
entity
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Source field: entity types
industry
Source field: industries
use
advance translational science, bring more treatments for all people more quickly, collaborative development of innovative approaches, technologies, or models, enhance the impact of research
Source field: use of funds
size limit

Not confirmed

Source field: applicant size limit
clause text

Eligibility for this NOFO is limited to recipients that have successfully competed for an award under the Clinical and Translational Science Awards (CTSA) UM1 NOFO PAR-24-272 or subsequent iterations, as either a prime recipient or as a…

We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.

When does it close?

Not statedDeadline type Not stated

What can the money be used for?

4 categorys
The source’s own spending categories, and what is not parsed.
collaborative development of innovative approaches, technologies, or modelsenhance the impact of researchadvance translational sciencebring more treatments for all people more quickly

These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.

How hard is the application?

1 field
Effort, match requirement and reimbursement, as the source stated them.
Application effort
Not confirmed
Disbursement
Not confirmed
Matching funds
No

Common questions

3 questions
Every answer is a stored field from this record. Questions the source did not answer are not asked.
Who is eligible to apply?
Others (see text field entitled "Additional Information on Eligibility" for clarification).
What can the funding be used for?
collaborative development of innovative approaches, technologies, or models, enhance the impact of research, advance translational science, bring more treatments for all people more quickly, as classified by the source.
Is matching funding required?
No. The source states that no matching funds are required.

AI summary of the source text

Optional. Every core field on this record is already above, free and complete.

AI summary of the source text

Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.

Included with Studio

Sign in
Provenance
Source pagegrants.gov
Retrieved2026-09-06
MethodAutomated check
First seen2026-09-06

The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.